1319MO Intracranial efficacy of HER3-DXd in patients with previously treated advanced EGFR-mutated NSCLC: Results from HERTHENA-Lung01
Year: 2023
Type: article
Source: Annals of Oncology
Authors: M.L. Johnson, P.A. Jänne, Y. Goto, K. Yoh, S-H. Lee, L. Paz-Ares, B. Besse, S. Novello, H. Hayashi, D-W. Kim, T. John, S.C-H. Kao, E. Felip, J.C-H. Yang, M. Reck, Q. Dong, A. Sporchia, D.W. Sternberg, H.A. Yu
Institutions: Tennessee Oncology, Dana-Farber Cancer Institute, National Cancer Center Hospital, National Cancer Center Hospital East, Samsung Medical Center, Sungkyunkwan University, Universidad Complutense de Madrid, Spanish National Cancer Research Centre, Hospital Universitario 12 De Octubre, Université Paris-Saclay, Ospedale San Luigi Gonzaga, University of Turin, Kindai University, Seoul National University, Seoul National University Hospital, Peter MacCallum Cancer Centre, The University of Sydney, Chris O’Brien Lifehouse, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, National Taiwan University Hospital, German Center for Lung Research, Daiichi Sankyo (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Celgene, Emory University, F. Hoffmann-La Roche, Regeneron Pharmaceuticals, Merck KGaA, Exelixis, National Cancer Centre of Singapore, Clovis Oncology, Mirati Therapeutics, BeiGene, Incyte, Yuhan, G1 Therapeutics, Bayer HealthCare, Daiichi-Sankyo, Chinese University of Hong Kong, Astellas Pharma, European Society for Medical Oncology, Sociedad Española de Oncología Médica, Taichung Veterans General Hospital, National University Cancer Institute, Singapore, Fundació Institut de Recerca Hospital Universitari Vall d’Hebron, PharmaMar, Ono Pharmaceutical, Grifols, University of Texas MD Anderson Cancer Center, Takeda Pharmaceuticals International, Daiichi Sankyo Europe, Cilag
OpenAlex ID: W4387825537